Awakn Life Sciences Archives

Psychedelics News

Awakn Life Sciences

Industry

7 Sep 2023

Awakn Life Sciences Submits Clinical Trial Application for Phase 3 Trial

Awakn Life Sciences has submitted a Clinical Trial Application for a phase III trial for its lead program for the treatment of Severe Alcohol Use Disorder....

By Microdose NewsDesk

Industry

2 Aug 2023

Awakn Life Sciences Completes Sale of Clinics; Shifts To Biotech Development

Awakn Life Sciences has sold its last clinic and shifted its focus entirely to its clinical trials and biotech research....

By Jason Najum

Industry

7 Feb 2023

Awakn Life Sciences Granted Fast-Track Designation from UK for Ketamine Therapy

Awakn Life Sciences continues to advance its primary program forward, receiving fast-track innovation approval from UK regulators....

By Jason Najum

Industry

20 Dec 2022

Top 5 Psychedelic Milestones of 2022

2022 was a big year for psychedelic medicine industry, we take a look at the top 5 psychedelic milestones for 2022...

By James Hallifax

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

21 Nov 2022

Nushama & Awakn Sign Agreement for Alcohol Disorder Treatment in NYC

NUSHAMA AND AWAKN BRING REVOLUTIONARY ALCOHOL USE DISORDER TREATMENT TO NEW YORK — EFFICACY AT A FRACTION OF THE USUAL COST...

By Microdose NewsDesk

Industry, Science

7 Sep 2022

A Deeper Look at Ketamine for Alcohol Use Disorder

The psychedelic compound ketamine is gaining particular attention for the treatment of alcohol use disorder (AUD), with clinical studies being conducted to explore its potential....

By Elisabetta Fato

Don’t Miss

25 Jul 2022

News You Might Have Missed: July 25th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Industry

20 Jul 2022

Awakn’s Phase 3 Trial Approved for Government Funding

The UK’s National Institute for Health and Care Research (NIHR) has approved grant funding for 66% of the costs of Awakn’s Phase III clinical trial exploring the use of ketamine-assisted...

By Microdose NewsDesk

Don’t Miss

18 Jul 2022

News You Might Have Missed: July 18th, 2022

Welcome to the News You Might Have Missed, a weekly roundup of psychedelic medicine headlines to help you catch up and stay informed....

By Microdose NewsDesk

Follow us on social

Latest News

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

Two New Studies Are Rewriting the Rules of Psychedelic Drug Development

Professional Training in Psychedelic Medicine

Psychedelic medicine is reshaping the future of mental health care. From the power of microdosing LSD to the promise of MDMA in PTSD, the world of medical psychedelics offers transformative possibilities. Our comprehensive, CE-accredited course provides you with the knowledge and understanding you need to tap into this groundbreaking field.

WordPress Ads

No Result

View All Result